Lis William 4
4 · Jasper Therapeutics, Inc. · Filed Apr 14, 2023
Insider Transaction Report
Form 4
Lis William
DirectorChief Executive Officer
Transactions
- Sale
Voting Common Stock
2023-04-13$1.44/sh−8,500$12,240→ 61,486 total
Footnotes (1)
- [F1]These shares were sold by the Reporting Person solely in order to satisfy certain tax obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units.